2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Tuesday, June 14, 2016

6:00pm-7:00pm: Initial Experience with Ledipasvir-Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation.

A. Weick, O. Sadiq, S.-M. Jafri, D. Moonka.

Poster Session D: Viral Hepatitis • Halls C&D

6:00pm-7:00pm: Initial Experience with the Bacterial Enzyme IdeS® (IgG Endopeptidase) for Desensitization of Highly-HLA Sensitized (HS) Patients.

S. Jordan,¹ J. Choi,¹ X. Zhang,¹ M. Haas,² A. Peng,¹ J. Kahwaji,¹ R. Villicana,¹ A. Vo.¹

Poster Session D: Late Breaking • Halls C&D

6:00pm-7:00pm: iNKT Cell Ligands Administered with Bone Marrow Cells Expand Allo-Specific Regulatory T Cells In Vivo and Establish Transplant Tolerance.

S. Miyairi,^1,2 T. Hirai,¹ M. Okumi,¹ Y. Ishii,³ K. Yamazaki,² K. Tanabe.¹

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection • Halls C&D

6:00pm-7:00pm: Innate Immune Signaling During Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation.

R. Sosa,¹ A. Zarrinpar,² C. Lassman,¹ R. Busuttil,² D. Gjertson,¹ J. Kupiec-Weglinski,¹ E. Reed.¹

Poster Session D: Ischemia Reperfusion Injury: Clinical Update • Halls C&D

6:00pm-7:00pm: Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.

L. Gallon,¹ J. Leventhal,¹ C. Dumur,² J. Mathew,¹ L. Nadimpalli,¹ A. Shetty,¹ S. Ildstad,³ V. Mas.²

Poster Session D: Clinical Science: Tolerance: Clinical Studies • Halls C&D

6:00pm-7:00pm: Introducing a Mobile Phone Application to Transplant Patients to Encourage Medication Compliance and Education in This At-Risk Cohort.

A. Zanetti Yabur, A. Rizzo, J. Graham, J. Rocca.

Poster Session D: Psychosocial and Treatment Adherence • Halls C&D

6:00pm-7:00pm: Is CMV Prophylaxis Effective in CMV-Seropositive Patients Receiving Thymoglobulin as Induction Therapy?

E. Feitosa, F. Agena, J. Reusing Jr, F. Lemos, E. David-Neto.

Poster Session D: Poster Session II: Kidney Complications-Other • Halls C&D

6:00pm-7:00pm: Is SVR Associated with Improved Hepatic Function in Hepatitis C Gen 1 Pts with Cirrhosis 1 Year After Completing Treatment with Sofosbuvir + Simeprevir +/- Ribavirin?

A. Modi,¹ J. Hermann,¹ H. Nazario,² S. Gonzalez,¹ J. Gripshover,³ M. Gautam,¹ J. Weinstein,² D. Potosky,³ M. Barnes,² A. Habib,² P. Mantry,² J. Trotter.¹

Poster Session D: Viral Hepatitis • Halls C&D

6:00pm-7:00pm: Is There a Link Between Proteinuria and Increased FGF-23 Levels in Renal Transplant Patients.

E. Tutal,¹ S. Sezer,¹ Z. Bal,¹ B. Demirci,¹ M. Haberal.²

Poster Session D: Poster Session II: Kidney Complications-Other • Halls C&D

6:00pm-7:00pm: Ischemia-Reperfusion Injury Following Transplantation: Implications for the Modulation of CXCL8 Chemokine Function.

B. Martinez Burgo,¹ S. Ali,¹ J. Kirby,¹ N. Sheerin,¹ S. Cobb,² D. Kashanin.³

Poster Session D: Late Breaking • Halls C&D